Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03414255 · ClinicalTrials.gov registry record · Phase 3
Micronized dHACM Injectable for the Treatment of Achille Tendonitis
A Phase 3 study, sponsored by MiMedx Group.
- Completed
- Registry status
- Phase 3
- Development phase
- 146
- Enrollment target
NCT03414255 is a Phase 3 study that has completed, run by MiMedx Group. The registered enrollment target is 146 participants.
The verdict
NCT03414255, a Phase 3 study, has completed, sponsored by MiMedx Group.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 146 participants
- Enrollment target
Study Summary
Prospective, Double-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to Saline Placebo Injection in the Treatment of Achilles Tendonitis
Interventions
- DRUG Saline Injection
- BIOLOGICAL Micronized DHACM
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 146 participants |
| Start Date | 2018-01-09 |
| Est. Completion | 2021-03-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03414255
The ClinicalTrials.gov registry entry for NCT03414255 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 146 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is MiMedx Group, which has 32 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Saline Injection is the first listed.
NCT03414255 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03414255 about?
NCT03414255 is a clinical study titled "Micronized dHACM Injectable for the Treatment of Achille Tendonitis". Prospective, Double-Blinded, Randomized Controlled Trial of the Micronized dHACM Injection as Compared to Saline Placebo Injection in the Treatment of Achilles Tendonitis
What is the current status of trial NCT03414255?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 146 participants. The study started on 2018-01-09. Estimated completion is 2021-03-30.
What interventions are being tested in trial NCT03414255?
The interventions under investigation include: Saline Injection (DRUG), Micronized DHACM (BIOLOGICAL).
Who is sponsoring clinical trial NCT03414255?
This trial is sponsored by MiMedx Group, which has 32 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.